Report - Wskazania do terapii biologicznej u chorych na · Anti-CD20 – ritukximab, crelizumab, afatumumab Anti-CD22 – epratuzumab Anti-Blys MoAb IgG1 – belimumab Anti-TNFα – MoAb

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form